Left atrial dysfunction: the next key target in heart failure with preserved ejection fraction

Masaru Obokata; Barry A. Borlaug

doi:10.1002/ejhf.1420

Left atrial dysfunction: the next key target in heart failure with preserved ejection fraction

Masaru Obokata, Barry A. Borlaug

Cardiovascular Medicine

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	506-508
Number of pages	3
Journal	European Journal of Heart Failure
Volume	21
Issue number	4
DOIs	https://doi.org/10.1002/ejhf.1420
State	Published - Apr 2019

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ejhf.1420

Cite this

@article{7a2d97d515d34129874a3f7021f6a907,

title = "Left atrial dysfunction: the next key target in heart failure with preserved ejection fraction",

author = "Masaru Obokata and Borlaug, {Barry A.}",

note = "Funding Information: Barry A. Borlaug is supported by R01 HL128526, R01 HL 126638, U01 HL125205 and U10 HL110262, all from the National Institute of Health. Masaru Obokata is supported by a research fellowship from the Uehara Memorial Foundation, Japan. Conflict of interest: none declared. Funding Information: Barry A. Borlaug is supported by R01 HL128526, R01 HL 126638, U01 HL125205 and U10 HL110262, all from the National Institute of Health. Masaru Obokata is supported by a research fellowship from the Uehara Memorial Foundation, Japan.",

year = "2019",

month = apr,

doi = "10.1002/ejhf.1420",

language = "English (US)",

volume = "21",

pages = "506--508",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Left atrial dysfunction

T2 - the next key target in heart failure with preserved ejection fraction

AU - Obokata, Masaru

AU - Borlaug, Barry A.

N1 - Funding Information: Barry A. Borlaug is supported by R01 HL128526, R01 HL 126638, U01 HL125205 and U10 HL110262, all from the National Institute of Health. Masaru Obokata is supported by a research fellowship from the Uehara Memorial Foundation, Japan. Conflict of interest: none declared. Funding Information: Barry A. Borlaug is supported by R01 HL128526, R01 HL 126638, U01 HL125205 and U10 HL110262, all from the National Institute of Health. Masaru Obokata is supported by a research fellowship from the Uehara Memorial Foundation, Japan.

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85061284886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061284886&partnerID=8YFLogxK

U2 - 10.1002/ejhf.1420

DO - 10.1002/ejhf.1420

M3 - Editorial

C2 - 30734449

AN - SCOPUS:85061284886

SN - 1388-9842

VL - 21

SP - 506

EP - 508

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 4

ER -

Left atrial dysfunction: the next key target in heart failure with preserved ejection fraction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this